Assessment of chemokine responses involved in the cerebral and mild malaria in murine model
DOI:
https://doi.org/10.7439/ijbr.v7i7.3422Abstract
Background: The role of chemokines on the integrity of Central Nervous system (CNS) during malaria infection remains unclear; we therefore, in this study investigated the alternation in gene expression of chemokines in the Brain samples of P. yoelii 17XL infected mice with Cerebral Malaria (CM) as well as Mild Malaria (MM). Objective: To evaluate the pro-inflammatory chemokine expression in the brain samples of murine CM and MM Methods: mRNA levels of IFN ?, IP-10, RANTES, MIP1-?, MIP1-? and MCP were measured by qRT-PCR in Brain samples of P. yoelii 17XL infected mice. GAPDH was used as the housekeeping gene. Histopathological studies of brain samples from infected and uninfected mice were conducted. Results: CM mice had highly up-regulated of all chemokines except IFN ? and RANTES than MM mice (all P 0.0001)); IFN ? (P=0.5133) and RANTES (P=0.9292) were found to be decreased in CM as compared to MM wherein IP-10 (P=0.1419), MIP1-? (P=0.1664), MIP1-? (P=0.6294) and MCP (P=0.8262) mRNA were significantly up regulated at peak parasitemia and remains high in the CM of experimental mouse model. Histopathology results revealed tissue section in severely parasitized mice exhibited massive degeneration of the parenchyma, consistent with marked inflammation. Conclusion: It might be concluded from the findings of the present study that up regulation of IP-10, MIP1?, MIP 1? and MCP-1 and low expression of IFN ? and RANTES in the brains of CM mice are associated with mortality of P.yoelii 17XL infected CM mice as compared to mice with MM.Downloads
References
Das A. The distinctive features of Indian malaria parasites. Trends in parasitology. 2015;31(3):83-6.
Sharma RK, Thakor HG, Saha KB, Sonal GS, Dhariwal AC, Singh N. Malaria situation in India with special reference to tribal areas. The Indian Journal of Medical Research. 2015;141(5):537-45.
Schofield L, Grau GE. Immunological processes in malaria pathogenesis. Nature reviews Immunology. 2005;5(9):722-35.
Ampawong S, Chaisri U, Viriyavejakul P, Nontprasert A, Grau GE, Pongponratn E. Electron microscopic features of brain edema in rodent cerebral malaria in relation to glial fibrillary acidic protein expression. International Journal of Clinical and Experimental Pathology. 2014;7(5):2056-67.
Campanella GS, Tager AM, El Khoury JK, Thomas SY, Abrazinski TA, Manice LA, et al. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(12):4814-9.
Grau GE, Mackenzie CD, Carr RA, Redard M, Pizzolato G, Allasia C, et al. Platelet accumulation in brain microvessels in fatal pediatric cerebral malaria. The Journal of Infectious Diseases. 2003;187(3):461-6.
Mitchell AJ, Hansen AM, Hee L, Ball HJ, Potter SM, Walker JC, et al. Early cytokine production is associated with protection from murine cerebral malaria. Infection and Immunity. 2005;73(9):5645-53.
Lou J, Lucas R, Grau GE. Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clinical Microbiology Reviews. 2001;14(4):810-20.
Hanum PS, Hayano M, Kojima S. Cytokine and chemokine responses in a cerebral malaria-susceptible or -resistant strain of mice to Plasmodium berghei ANKA infection: early chemokine expression in the brain. International immunology. 2003;15(5):633-40.
de Souza JB, Hafalla JC, Riley EM, Couper KN. Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology. 2010;137(5):755-72.
Shear HL, Marino MW, Wanidworanun C, Berman JW, Nagel RL. Correlation of increased expression of intercellular adhesion molecule-1, but not high levels of tumor necrosis factor-alpha, with lethality of Plasmodium yoelii 17XL, a rodent model of cerebral malaria. The American Journal of Tropical Medicine And Hygiene. 1998;59(6):852-8.
Hansen DS. Inflammatory responses associated with the induction of cerebral malaria: lessons from experimental murine models. PLoS pathogens. 2012;8(12):e1003045.
Kaul DK, Nagel RL, Llena JF, Shear HL. Cerebral malaria in mice: demonstration of cytoadherence of infected red blood cells and microrheologic correlates. The American Journal of Tropical Medicine And Hygiene. 1994;50(4):512-21.
Sarfo BY, Armah HB, Irune I, Adjei AA, Olver CS, Singh S, et al. Plasmodium yoelii 17XL infection up-regulates RANTES, CCR1, CCR3 and CCR5 expression, and induces ultrastructural changes in the cerebellum. Malaria Journal. 2005;4:63
John CC, Opika-Opoka R, Byarugaba J, Idro R, Boivin MJ. Low levels of RANTES are associated with mortality in children with cerebral malaria. The Journal of Infectious Diseases. 2006;194(6):837-45.
Ioannidis LJ, Nie CQ, Hansen DS. The role of chemokines in severe malaria: more than meets the eye. Parasitology. 2014;141(5):602-13.
Murdoch C, Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood. 2000;95(10):3032-43.
Debiasi RL, Tyler KL. West Nile virus meningoencephalitis. Nature clinical practice Neurology. 2006;2(5):264-75.
Armah HB, Wilson NO, Sarfo BY, Powell MD, Bond VC, Anderson W, et al. Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malaria Journal. 2007;6:147.
Cavaillon JM, Adib-Conquy M, Fitting C, Adrie C, Payen D. Cytokine cascade in sepsis. Scandinavian Journal of Infectious Diseases. 2003; 35(9):535-44.
Carrol ED, Thomson AP, Mobbs KJ, Hart CA. The role of RANTES in meningococcal disease. The Journal of Infectious Diseases. 2000;182(1):363-6.
Ochiel DO, Awandare GA, Keller CC, Hittner JB, Kremsner PG, Weinberg JB, et al. Differential regulation of beta-chemokines in children with Plasmodium falciparum malaria. Infection and Immunity. 2005;73(7):4190-7.
Sarfo BY, Singh S, Lillard JW, Jr., Quarshie A, Gyasi RK, Armah H, et al. The cerebral-malaria-associated expression of RANTES, CCR3 and CCR5 in post-mortem tissue samples. Annals of Tropical Medicine and Parasitology. 2004;98(3):297-303.
Dechkum N, Hananantachai H, Patarapotikul J, Ohashi J, Krudsood S, Looareesuwan S, et al. Monocyte chemoattractant protein 1 (MCP-1) gene polymorphism is not associated with severe and cerebral malaria in Thailand. Japanese Journal of Infectious Diseases. 2006;59(4):239-44.
Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte
chemoattractant protein-1 (MCP-1): an overview. Journal of Interferon & Cytokine Research : the official Journal of the International Society for Interferon and Cytokine Research. 2009;29(6):313-26.
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402-8.
Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nature protocols. 2008;3(6):1101-8.
Linares M, Marin-Garcia P, Perez-Benavente S, Sanchez-Nogueiro J, Puyet A, Bautista JM, et al. Brain-derived neurotrophic factor and the course of experimental cerebral malaria. Brain Research. 2013;1490:210-24.
Jain V, Armah HB, Tongren JE, Ned RM, Wilson NO, Crawford S, et al. Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malaria Journal. 2008;7:83.
Harrison AM, Bonville CA, Rosenberg HF, Domachowske JB. Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation. American Journal of Respiratory and Critical Care Medicine. 1999;159(6):1918-24.
Jaramillo M, Plante I, Ouellet N, Vandal K, Tessier PA, Olivier M. Hemozoin-inducible proinflammatory events in vivo: potential role in malaria infection. J Immunol. 2004;172(5):3101-10.
Stamatovic SM, Shakui P, Keep RF, Moore BB, Kunkel SL, Van Rooijen N, et al. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 2005; 25(5):593-606.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- An author must submit Copyright form After acceptance of the article.